DK1000062T3 - Tricykliske vasopressinagonister - Google Patents

Tricykliske vasopressinagonister

Info

Publication number
DK1000062T3
DK1000062T3 DK98938017T DK98938017T DK1000062T3 DK 1000062 T3 DK1000062 T3 DK 1000062T3 DK 98938017 T DK98938017 T DK 98938017T DK 98938017 T DK98938017 T DK 98938017T DK 1000062 T3 DK1000062 T3 DK 1000062T3
Authority
DK
Denmark
Prior art keywords
vasopressin agonists
tricyclic
tricyclic vasopressin
agonists
vasopressin
Prior art date
Application number
DK98938017T
Other languages
Danish (da)
English (en)
Inventor
John Paul Dusza
Jay Donald Albright
Jehan Framroz Bagli
Amedeo Arturo Failli
Mark Anthony Ashwell
Thomas Joseph Caggiano
Eugene John Trybulski
Peter Sinchun Chan
Albert John Molinari
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK1000062T3 publication Critical patent/DK1000062T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK98938017T 1997-07-30 1998-07-24 Tricykliske vasopressinagonister DK1000062T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90336997A 1997-07-30 1997-07-30
EP98938017A EP1000062B1 (de) 1997-07-30 1998-07-24 Trizyclische vasopressin agoniste
PCT/US1998/015495 WO1999006409A1 (en) 1997-07-30 1998-07-24 Tricyclic vasopressin agonists

Publications (1)

Publication Number Publication Date
DK1000062T3 true DK1000062T3 (da) 2004-11-22

Family

ID=25417392

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98938017T DK1000062T3 (da) 1997-07-30 1998-07-24 Tricykliske vasopressinagonister

Country Status (22)

Country Link
EP (1) EP1000062B1 (de)
JP (1) JP4338305B2 (de)
KR (1) KR100580805B1 (de)
CN (1) CN1183134C (de)
AR (1) AR016557A1 (de)
AT (1) ATE277050T1 (de)
AU (1) AU756959B2 (de)
BR (1) BR9811585A (de)
CA (1) CA2297406C (de)
DE (1) DE69826487T2 (de)
DK (1) DK1000062T3 (de)
ES (1) ES2229525T3 (de)
HU (1) HUP0002480A3 (de)
IL (1) IL133788A0 (de)
NO (1) NO315273B1 (de)
NZ (1) NZ502449A (de)
PT (1) PT1000062E (de)
RU (1) RU2213094C2 (de)
SI (1) SI1000062T1 (de)
TW (1) TW502035B (de)
WO (1) WO1999006409A1 (de)
ZA (1) ZA986784B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
BRPI9917086B8 (pt) * 1999-01-19 2016-05-24 Ortho Mcneil Pharm Inc benzodiazepina tricíclica, suas composições farmacêuticas bem como compostos intermediários
AU7615200A (en) * 1999-09-27 2001-04-30 American Cyanamid Company Vasopressin agonist formulation and process
US6831079B1 (en) * 1999-09-27 2004-12-14 American Cyanamid Company Vasopressin agonist formulation and process
GB0000079D0 (en) * 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
GB0015601D0 (en) 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
US6900200B2 (en) 2001-04-12 2005-05-31 Wyeth Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US7202239B2 (en) 2001-04-12 2007-04-10 Wyeth Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
US7109193B2 (en) 2001-04-12 2006-09-19 Wyeth Tricyclic diazepines tocolytic oxytocin receptor antagonists
US7326700B2 (en) 2001-04-12 2008-02-05 Wyeth Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US7022699B2 (en) 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
US7064120B2 (en) 2001-04-12 2006-06-20 Wyeth Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US6903087B2 (en) 2001-04-12 2005-06-07 Wyeth Pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US6977254B2 (en) 2001-04-12 2005-12-20 Wyeth Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
AU2002342045C1 (en) * 2001-10-12 2009-07-30 Azevan Pharmaceuticals, Inc. Beta-lactamyl vasopressin Vla antagonists
ATE512951T1 (de) 2003-04-28 2011-07-15 Astellas Pharma Inc 4,4-difluor-1,2,3,4-tetrahydro-5h-1- benzazepinderivat oder salz davon
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds
EP1784408A1 (de) * 2004-08-25 2007-05-16 Pfizer Limited Triazolobenzodiazepine und ihre verwendung als vasopressin-antagonisten
CN104922117A (zh) 2005-03-22 2015-09-23 阿泽范药品公司 用于治疗月经前病症的β-内酰氨基链烷酸
CN102216305B (zh) 2008-11-13 2013-12-18 弗·哈夫曼-拉罗切有限公司 螺-5,6-二氢-4H-2,3,5,10b-四氮杂-苯并[e]薁类
EP2308866A1 (de) 2009-10-09 2011-04-13 Bayer CropScience AG Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide
US8420633B2 (en) * 2010-03-31 2013-04-16 Hoffmann-La Roche Inc. Aryl-cyclohexyl-tetraazabenzo[e]azulenes
GB201005623D0 (en) 2010-04-01 2010-05-19 Vantia Ltd New polymorph
US8461151B2 (en) * 2010-04-13 2013-06-11 Hoffmann-La Roche Inc. Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes
US8481528B2 (en) * 2010-04-26 2013-07-09 Hoffmann-La Roche Inc. Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8513238B2 (en) * 2010-05-10 2013-08-20 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes
US9376424B2 (en) 2010-07-01 2016-06-28 Azevan Pharmaceuticals, Inc. Methods for treating post traumatic stress disorder
AR094929A1 (es) 2013-02-28 2015-09-09 Bristol Myers Squibb Co Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2
WO2014134391A1 (en) 2013-02-28 2014-09-04 Bristol-Myers Squibb Company Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
FI3122743T3 (fi) 2014-03-28 2023-03-02 Azevan Pharmaceuticals Inc Koostumuksia ja menetelmiä hermostoa rappeuttavien sairauksien hoitamiseksi
JP2020534274A (ja) 2017-09-15 2020-11-26 アゼヴァン ファーマシューティカルズ，インコーポレイテッド 脳損傷を治療するための組成物及び方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516774A (en) * 1993-07-29 1996-05-14 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
US5521173A (en) * 1995-01-17 1996-05-28 American Home Products Corporation Tricyclic benzazepine vasopressin antagonists
TW359669B (en) * 1995-12-15 1999-06-01 Otsuka Pharma Co Ltd Benzazepine derivatives

Also Published As

Publication number Publication date
HUP0002480A3 (en) 2002-09-30
PT1000062E (pt) 2004-12-31
CN1183134C (zh) 2005-01-05
NO20000242D0 (no) 2000-01-18
NO315273B1 (no) 2003-08-11
TW502035B (en) 2002-09-11
KR100580805B1 (ko) 2006-05-17
ES2229525T3 (es) 2005-04-16
HUP0002480A2 (hu) 2000-11-28
EP1000062A1 (de) 2000-05-17
AR016557A1 (es) 2001-07-25
NZ502449A (en) 2002-08-28
BR9811585A (pt) 2000-09-26
NO20000242L (no) 2000-03-06
IL133788A0 (en) 2001-04-30
DE69826487D1 (de) 2004-10-28
CN1272111A (zh) 2000-11-01
CA2297406A1 (en) 1999-02-11
ZA986784B (en) 2000-06-22
DE69826487T2 (de) 2005-12-01
AU756959B2 (en) 2003-01-30
SI1000062T1 (en) 2004-12-31
CA2297406C (en) 2009-02-24
JP2001512125A (ja) 2001-08-21
ATE277050T1 (de) 2004-10-15
KR20010022398A (ko) 2001-03-15
JP4338305B2 (ja) 2009-10-07
EP1000062B1 (de) 2004-09-22
AU8663398A (en) 1999-02-22
WO1999006409A1 (en) 1999-02-11
RU2213094C2 (ru) 2003-09-27

Similar Documents

Publication Publication Date Title
DK1000062T3 (da) Tricykliske vasopressinagonister
DE69831821D1 (de) Hochleitungs-zweischichtigesreibungsmaterial
ATE250583T1 (de) Substituierte 3-cyanochinoline
DE69831181D1 (de) Positionsbestimmung
DK0805813T3 (da) Tricyclic vasopressin antagonists
DE69839157D1 (de) Fullurene enthaltendes katherdersystem
NO982686L (no) R°rledningsplugg
DE69819234D1 (de) Vorhängeschloss
NO994850D0 (no) Farmakologiske midler
DE69818447D1 (de) Verbesserungen bezüglich der bilderzeugung
PT1036083E (pt) Novos 9a-azalidos
DE59813487D1 (de) Substituierte 4-benzoyl-pyrazole
NO995147D0 (no) Kontrastmidler
DK0983266T3 (da) Hidtil ukendte tetrahydrosioquinolinthiophencarboximidamider
ATE244705T1 (de) Substituierte 4-benzoyl-pyrazole
NO974892L (no) Ventilasjonsr°r
ID24079A (id) Aminoheteroksiklilamida tersubstitusi
FR2770398B1 (fr) Chaussette massante
DE69800318D1 (de) Photolumineszierende Polydisilacyclobutane
DE69800541T2 (de) Photolumineszierende Polydisilacyclobutane
DE59807877D1 (de) Substituierte 4-benzoyl-pyrazole
DE59810960D1 (de) Substituierte phenyluracile
SE9704399D0 (sv) New combination
NO985400D0 (no) L°fteanordning
NO974532L (no) L°fteanordning